This inventor holds 1 USPTO granted patent. Top assignee: Vaxon Biotech. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Sébastien Cornet: Innovator in Anti-Cancer Vaccines
Introduction
Sébastien Cornet is a notable inventor based in Lille, France. He has made significant contributions to the field of anti-cancer vaccines through his innovative research and development.
Latest Patents
Cornet holds a patent for an immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides. This invention pertains to the development of anti-cancer vaccines and includes an optimized polypeptide that comprises three cryptic tumor peptides with enhanced immunogenicity. The amino acid sequence YLQVNSLQTVYLEYRQVPVYLEEITGYL (SEQ ID NO. 2) is a key component of this invention. Additionally, the patent covers nucleic acids encoding such a polypeptide, as well as engineered dendritic cells and complexes utilizing this polypeptide or its encoding nucleic acid.
Career Highlights
Sébastien Cornet has established himself as a prominent figure in the biotechnology sector. He is currently associated with Vaxon Biotech, where he continues to advance his research in immunology and cancer treatment.
Collaborations
Cornet collaborates with various professionals in the field, including his coworker Kostantinos Kosmatopoulos, to enhance the development of innovative solutions in cancer therapy.
Conclusion
Sébastien Cornet's work in the field of anti-cancer vaccines exemplifies the impact of innovative research on healthcare. His contributions are paving the way for new therapeutic approaches in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile